Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates
Roivant Sciences Ltd. Common Shares · PHARMACEUTICAL PREPARATIONS · Now $29.09
+8.2% in 3d after detection
Post-detection moves
1h
—
1d
-1.2%
3d
+8.2%
7d
+4.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS